# GLP-1 Receptor Agonists: A New Treatment in Parkinson’s Disease

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/glp-1-receptor-agonists-a-new-treatment-in-parkinson-s-disease/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Kallirhoe Kalinderi,Vasileios Papaliagkas,Liana Fidani |
| Citations | 89 |
| DOI | 10.3390/ijms25073812 |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://www.mdpi.com/1422-0067/25/7/3812/pdf?version=1711698187 |
| OpenAlex ID | https://openalex.org/W4393950379 |
| PMID | 38612620 |
| Type | article |
| Year | 2024 |

## Paper authors

- [Vasileios Papaliagkas](https://scholariq.org/researchers/vasileios-papaliagkas/)

## Paper journal

- [International Journal of Molecular Sciences](https://scholariq.org/journals/international-journal-of-molecular-sciences/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Parkinson's Disease Mechanisms and Treatments](https://scholariq.org/topics/parkinson-s-disease-mechanisms-and-treatments/)
- [Pancreatic function and diabetes](https://scholariq.org/topics/pancreatic-function-and-diabetes/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.